Alzheimer Disease Clinical Trial
Official title:
Effects of Visual Arts Training on Dementia
The study will use a randomized controlled trial to test the efficacy of two interventions
(visual arts and music) for individuals with dementia, focusing on dementia of the
Alzheimer's type (DAT). Interventions will be run for 10 weeks in dementia day centers
and/or retirement residences. Participants will be tested before and after the intervention
on a battery of cognitive, affective, and behavioural measures. They will be compared to a
waitlist control group who don't receive the intervention.
The purpose of our research is twofold: treatment of symptoms and improved quality of life
during disease progression in dementia. For the primary aim, the investigators are examining
the potential of arts interventions on declining functions in dementia (memory, mood, and
behavior) to investigate potential treatment effects. Secondly, quality of life will be
measured, with the aim of looking beyond disease progression to contribute to an overall
positive patient experience. Research has indicated the need for non-pharmacological
treatments to be used as a first line of action against dementia symptoms and development.
While, in best practice, pharmacological treatments should be used as a second-line
approach.
Note: Music intervention dropped prior to study initiation.
Participants
Older adults age 65 and older, both males and females, with normal or corrected vision and
hearing. Participants will require a diagnosis of dementia, with no other known comorbid
cognitive or neurological impairments.
Participants will be randomly allocated to one of three groups
1. Visual arts intervention group
2. Music intervention group
3. Waitlist control group (receiving the intervention after the completion of both testing
sessions).
Data analysis
1. Mixed 2x3 analysis of variance (ANOVA) for each construct, with within-subject factor
of time (pre-intervention and post-intervention) and between-subject factor of group
(visual arts, music, control).
2. Test for confounding effects of background factors (socioeconomic status, education
level, gender, activity participation).
3. Mediation analyses for effects of mood on cognition and behaviour.
Procedure
The present study is a randomized controlled trial assessing three groups of dementia
patients: a visual art group, a music group, and a non-art waitlist control group.
Randomized control trials are needed in dementia research because few experimental studies
exist to support that training has a causal influence on dementia related decline. Older
adults with dementia will be allocated to either a visual art group, music group, or
waitlist control group. Using two arts forms enables us to have active control groups to
examine the specificity of observed effects.
To address inconsistencies and methodological issues in existing results, the current study
will use rigorous experimental control, such as allocation concealment, adequate sample
size, and tester blinding. Based on a power calculation using effect sizes from previous
studies, each group will have sixty participants for an adequately powered sample.
Participants will be recruited by contacting activity administrators at dementia retirement
residences and day programs. Attention has and will be taken to prevent attrition, such as
tailoring interventions towards participants' needs and capacities, and by involving
families and caregivers in the research. Furthermore, the intervention and assessments will
be conducted at the participant's respective care facility. Currently, the investigators
have an established partnership with day dementia programs in the Toronto area, and will be
negotiating agreements to work with other senior retirement residences and day programs.
Recruiting from multiple locations and randomly assigning participants to experimental or
control groups will help with generalizability of results.
Following previous studies, the art interventions will take place over ten weeks (one hour
per day, two days per week). The visual art course will be a drawing course focusing on
basic visual art concepts (such as shape and contrast) and the music course will be a
singing and instrumental course focusing on basic music concepts (such as rhythm and
melody). Defining training elements will delineate the specific effects of different
activities on cognition, a poorly explored area in previous studies. The visual arts and
music courses will be taught by the study's graduate student investigators (Annalise D'Souza
and Katherine Matthews). Both teachers have experience and accreditations in their
respective art.
Before and after both courses, all participants (wait-list control group included) will
complete multiple assessment tasks. Data will be analyzed using mixed analyses of variance
to compare performance for each participant at both testing sessions, and between groups.
The pre-tests will occur one to two weeks before the beginning of the arts courses, and the
post-tests will occur during the two weeks after the art courses are finished. Testing will
occur over a two day period, for one hour per day to accommodate participants attention span
and cognitive load. All tasks have been selected for their reliability, validity, and their
suitability to the population at hand. To investigate specific influences of each art,
separate visual and auditory/verbal tests will be used for each measure. Testing and courses
will begin in early 2015, and will be run multiple times at different locations to reach the
targeted sample size, with expected start dates in April, September, and January.
Participant recruitment for these courses will begin in April and continue until December.
Based on previous discussions with dementia day programs, and the attrition and admission
rates of these programs, attaining sixty participants per group by December will be possible
if the investigators continue recruiting from multiple day programs and retirement
residences.
The participants' involvement in the study is completely voluntary and the participant and
their caregiver (if substitute consent is required) may choose to stop their participation
at any time. In the event the participant withdraws from the study all associated collected
data will be immediately destroyed wherever possible. All information the participant
supplies during the study will be held in confidence. Confidentiality will be provided to
the fullest extent possible by law.
Hypotheses
Predictions are outlined in the hypotheses below:
1. Visual art and music training will offset some of the decline in cognitive functions
(working memory, long-term memory, selective attention, dual-tasking, and task
switching).
a. Effects of visual art will be greater on visual measures of cognition and effects of
music will be greater on auditory measures
2. Visual art and music training will improve mood and lessen problematic behavior.
3. Visual art and music training will improve overall quality of life.
4. Mood will mediate some of the changes in cognition and behaviour
Background
The present study focuses on non-pharmacological art interventions for persons with
Alzheimer's disease and related dementias. Arts interventions will be designed and
implemented to investigate the effects of arts training on disease symptomology and overall
quality of life for persons with dementia. Dementia can be characterized by declining
cognitive functions, accompanied by a loss of daily functioning (DSM-IV, 2000), with a range
of cognitive, behavioural, and psychological deficits for different types of dementia.
The study will use a randomized controlled trial to test efficacy of two arts interventions.
Arts and dementia experts will guide intervention design to ensure that programs are
powerful and controlled. With the aims of reliability and applicability, interventions will
be created that can be tested by future researchers and applied by real-world practitioners.
Effects will be evaluated with a broad range of measures (affective, cognitive, and
behavioural. The proposed study is significant for two reasons. First, it addresses a
repeatedly highlighted need for non-pharmacological interventions in treating dementia.
Second, it looks beyond disease treatment alone by looking to also improve overall quality
of life in patients with dementia.
Non-pharmacological interventions offer great potential for mental improvement, but further
experimental research is needed before efficacy is established. A large evidence base
demonstrates a cognitive benefit of arts on healthy older adults. It is uncertain however,
whether such findings also apply to individuals with dementia. A few preliminary studies
indicate similar benefits can be found, but not all studies have reported cognitive
improvements following arts interventions in this patient population. In addition,
prospective studies indicate a link between dementia and cognitively stimulating activities
such as the arts. For example, it has been supported that older adults who participate in
more stimulating activities also display fewer incidences of dementia and Alzheimer's
disease.
Research suggests that non-pharmacological treatments should be used as a first line of
action against dementia, while pharmacological treatments should serve as a second-line
approach. While non-pharmacological treatments have indicated remedial effects, there is a
need for reliably conducted experiments to establish efficacy. Art recreation is easy to
administer, inexpensive and non-time consuming. Unlike the majority of current
pharmacological treatments, it is a noninvasive and pleasurable activity, and maintains the
personhood of the individual with dementia.
Note: Music intervention dropped prior to study initiation, due to insufficient participant
recruitment.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
| Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
| Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
| Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
| Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
| Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
| Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
| Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
| Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |